Mark W Frohlich
CIK 1420482 · See Remarks · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$229.9K
Companies
2
Total Filings
57
Lifetime Open-Market Net
-$705.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | Director | 7,000 | $32.85 | $229.9K | $0 | 3 | 2026-05-19 |
| Juno Therapeutics, Inc. (JUNO) Delisted | See Remarks | 919,583 | — | — | -$705.3K | 3 | 2016-03-02 |
Recent Filings · Page 3 of 6
57 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-05 | — | Grant (A) | +150,000 | $0 | |
| 2011-11-16 | — | Mixed | −6,252 | -$47.9K | |
| 2011-10-25 | — | Sell (S) | −3,230 | -$32.8K | |
| 2011-08-08 | — | Exer (M) | +11,362 | $66.5K | |
| 2011-07-25 | — | Sell (S) | −3,230 | -$126.4K | |
| 2011-06-08 | — | Exer (M) | +5,900 | $30.7K | |
| 2011-05-03 | — | Sell (S) | −18,000 | -$731.4K | |
| 2011-04-25 | — | Sell (S) | −3,230 | -$130.8K | |
| 2011-04-18 | — | Sell (S) | −4,282 | -$171.3K | |
| 2011-01-24 | — | Mixed | +18,788 | -$79.3K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.